cytarabine has been researched along with du-21220 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Inoue, D; Nishijima, K; Takahashi, J; Yoshida, Y | 1 |
2 other study(ies) available for cytarabine and du-21220
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A delayed diagnosis of acute myeloid leukaemia during pregnancy using an old blood cell analyser.
Topics: Adult; Blood Cell Count; Cesarean Section; Cytarabine; Delayed Diagnosis; Female; Gestational Age; Humans; Isoflavones; Leukemia, Myeloid, Acute; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy, Twin; Remission Induction; Ritodrine | 2019 |